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Proliferating cell nuclear antigen is required for
loading of the SMCX/KMD5C histone
demethylase onto chromatin
Zhihui Liang1,5, Marc Diamond1,6, Johanna A Smith1, Matthias Schnell2 and René Daniel1,3,4*

Abstract
Background: Histone methylation is regulated by a large number of histone methyltransferases and demethylases.
The recently discovered SMCX/KMD5C demethylase has been shown to remove methyl residues from lysine 4 of
histone H3 (H3K4), and constitutes an important component of the regulatory element-1-silencing transcription
factor (REST) protein complex. However, little is known about the cellular mechanisms that control SMCX activity
and intracellular trafficking.
Results: In this study, we found that small interfering RNA-mediated knockdown of proliferating cell nuclear
antigen (PCNA) resulted in the reduction of the chromatin-bound SMCX fraction. We identified a PCNA-interaction
protein motif (PIP box) in the SMCX protein. Using site-directed mutagenesis, we found that the amino acids of
the SMCX PIP box are involved in the association of SMCX with PCNA and its interaction with chromatin.
Conclusions: Our data indicate that the intracellular trafficking of SMCX is controlled by its association with PCNA.

Background
Cellular DNA in eukaryotes is organized in chromatin,
which contains a multitude of proteins. Histone proteins
comprise a major structural component of chromatin.
Histones carry diverse post-translational modifications,
particularly on the lysines of their N-terminus. These
modifications include methylation, acetylation, ubiquitylation and phosphorylation [1-4]. Histone modifications
are involved in crucial cellular processes, including transcription, DNA replication, and the DNA-damage
response [1,3,5]. As might be expected, chromatin and
histones undergo major reorganization during DNA
replication. After replication, the appropriate chromatin
structure has to be restored in order to maintain the passage of information from mother to daughter cells.
One of the major histone modifications is methylation
of the lysine 4 residue of histone H3 (H3K4). Trimethylation of H3K4 is a hallmark of active transcription, and
conversely, a loss of this modification represses transcription. Histone methylation is a very stable modification
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compared with, for example, acetylation. It had been long
thought that this modification was irreversible [6]. This
was supported by the fact that histone methyltransferases
were identified, but their counterparts, histone demethylases, were not yet known. This situation changed with
the first discovery of a histone demethylase, termed
lysine-specific demethylase (LSD)1 [7]. LSD1 prefers double-methylated H3K4 as its substrate [7]. Following this
discovery, many other histone demethylases were discovered, with various preferences for specific methylated histone residues. One of the newly discovered demethylases
is SMCX (Smcy homolog, X-linked (mouse); also termed
lysine-specific demethylase 5C (KDM5C) and jumonji,
AT rich interactive domain 1C (JARID1C)) [8].
SMCX is a ubiquitously expressed protein, which has
been linked to mental retardation [9-14]. In addition, a
novel mutation in the SMCX gene was found in a patient
with autism spectrum disorder (ASD) [15]. SMCX contains a JmjC domain, and belongs to a family of demethylases, which includes the Y-linked homolog SMCY,
retinoblastoma binding protein (RBP)2, and; lysine-specific
demethylase 5B (KDM5B; also termed PLU-1) [8,16]. In
addition to JmjC, SMCX also contains the N-terminal
plant homeodomain (PHD) finger, which binds to the
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trimethylated H3K4 (H3K4me3). SMCX reverses H3K4
me3 to di- and mono-, but not unmethylated products [8].
SMCX was reported to function as a transcriptional
repressor, and its loss impairs neuronal gene regulation
mediated by regulatory element-1-silencing transcription
factor (REST) [17,18]. However, little is known about how
the SMCX-mediated demethylase activity is regulated during the cell cycle and other crucial cellular processes.
In this study, we found that SMCX-mediated H3K4
demethylation is regulated by proliferating cell nuclear
antigen (PCNA). We show that association of SMCX with
chromatin and H3K4me3 demethylation depends on
PCNA. Further, we identified a aconserved sequence
motif, [NQ]xx(L/I/M/V)xx (F/Y/W), called the PCNAinteraction protein motif (PIP box) in the SMCX protein.
Finally, site-directed mutagenesis demonstrates that the
PIP box is important for SMCX association with PCNA.

Methods
Cells, plasmids and PIP BOX mutants

We used 293T/17 cells (referred to as ‘293T’ from this
point onwards) (catalog number CRL-11268; American
Type Culture Collection (ATCC) Manassas, VA, USA),
which were maintained in DMEM medium supplemented
with 10% FBS and antibiotics (Penn/Strep at 1:100).
A pCMV6-XL6 vector with SMCX cDNA was used
(Origene Technologies, Rockville, MD, USA and expressed
from the cytomegalovirus (CMV) promoter (number
SC128277;). The PIP box in SMCX and G9a were identified using a ScanProsite search for conserved motifs in
SMCX and G9a sequences. PIP box mutants were
obtained by site-directed mutagenesis of the SMCXencoding plasmid of residues F, L and Q, respectively, into
A, and confirmed using sequencing and other standard
methods.
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at 24-hour intervals. Cells were subsequently harvested at
48 hours after the first transfection, and lysed for immunoblotting experiments.
Antibodies and beads

The antibodies used were: anti-histone H3 (number
ab1791-100), anti-SMCX (number ab72152 for Figures 1,
2 and 3, and ab34718 for Figures 4 and 5), a and antiH3K4me3 (number ab8580) (all Abcam, Cambridge, Cambridgeshire, UK); anti-PCNA (number sc-56), Trim5
(number sc-48319) and anti-GAPDH (number sc-2037)
(all Santa Cruz Biotechnology Inc., Santa Cruz, CA, USA);
Anti-BrdU conjugated to Alexa Fluor 594 (number
A21304) and secondary donkey anti-rabbit conjugated to
Alexa Fluor 488 (number A21206) (both Invitrogen Corp).
Preparation of chromatin fractions and western blotting

The cells were washed with PBS once, then pelleted by
centrifugation. Pellets were resuspended in lysis buffer
with 1% Triton X-100 and fresh protease inhibitors, and
incubated on ice for 5 minutes. Lysates were then separated by centrifugation at 13,000 rpm for 5 minutes. The
resulting supernatant contained cytoplasmic and nuclear

SMCX

PCNA
Transfections

Regularly maintained 293T cells were plated into cell-culture dishes with DMEM and 10% inactivated FBS, 1 day
before transfection. The following day, the plates were
transfected using Lipofectamine™ 2000 (number
11668027; Invitrogen Corp., Carlsbad, CA, USA), when
transfected with small interfering (si)RNA and plasmid
DNA, or Lipofectamine™ RNAiMAX (number
13778075; Invitrogen Corp.) when transfected with
siRNA (targeting PCNA) alone.
Small interfering RNAs

Pools of PCNA siRNA, G9a siRNA and the non-targeting
control siRNA sequences were synthesized (numbers M003289-02-0010, M-006937-01-0005 and P-001206-1305 respectively; Dharmacon Research Inc., Lafayette, CO,
USA). To deplete PCNA, 293T cells were transfected
twice (Lipofectamine™ 2000) with the indicated siRNAs

Trim5D
D
H3
H3K4me3
Figure 1 Effect of proliferating cell nuclear antigen (PCNA)
knockdown on the intracellular distribution of exogenous
SMCX (Smcy homolog, X-linked (mouse)) protein. 293T cells
were transfected with the SMCX-encoding plasmid or the control
empty vector, and PCNA or control small interfering (si)RNA. Two
days after transfection, cells were harvested, then the chromatin
fraction was separated from the rest of the lysate and the fractions
analyzed by western blotting. The four samples on the left are of
SMCX and PCNA levels in chromatin, and those on the right are
SMCX levels in the whole-cell lysate without chromatin fraction.
Histone H3 (chromatin protein) and TRim5a (cytoplasmic protein),
respectively, were used as loading controls. The label ‘Vector’
indicates cells transfected with the empty plasmid vector.
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SMCX (W-Ch)
SMCX (Ch)
PCNA

proteins without the chromatin fraction. The chromatincontaining pellet was resuspended in the sample buffer
containing SDS, and denatured by heating at 90°C for 10
minutes; it was then incubated on ice for 5 minutes.
Before loading onto SDS-PAGE gels, samples were treated
with sonication to break up DNA, and separated by centrifugation. After electrophoresis, samples were transferred
to a membrane (Immobilon P; number IPVH00010; Millipore, Billerica, MA, USA), and incubated with primary
and secondary antibodies in 5% milk. The Santa Cruz antibodies were diluted 1:200, and all other antibodies were
diluted 1:1000. All secondary antibodies were diluted
1:5000. Bands were detected using chemiluminescence.
Immunoprecipitation

The cells were harvested and chromatin lysates prepared
as described previously [19]. The immunoprecipitation
was carried out at 4°C overnight by incubating the lysates
with the primary antibody of interest or a normal IgG
(Santa Cruz, rabbit IgG sc2027, mouse IgG sc-2025). The
after day, protein-antibody complexes were isolated by
binding to protein G plus/protein A agarose (number
IP05; Calbiochem-Novabiochem International, Inc., La
Jolla, CA, USA). for 1 hour at 4°C. Immunoprecipitates
were collected and washed 3 times with the lysis buffer,
resuspended in the SDS sample buffer and heated for
5 minutes at 90°C. The protein G plus/protein A agarose

H3
Figure 2 Effect of proliferating cell nuclear antigen (PCNA)
knockdown on intracellular distribution of endogenous SMCX
(Smcy homolog, X-linked (mouse)) protein. 293T cells were
transfected with anti-PCNA or control small interfering (si)RNA. Two
days after transfection, cells were harvested, then the chromatin
fraction was separated from the rest of the lysate and fractions
analyzed by western blotting. Ch = chromatin fraction, W-Ch = cell
lysate without chromatin.
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Figure 3 Cell-cycle regulation of SMCX (Smcy homolog, X-linked (mouse)). (A) SMCX levels in cells treated with and stained for (5-bromo2’-deoxyuridine, BrdU). Cells were exposed to BrdU for 3 hours then double-stained with anti-BrdU and SMCX antibodies. Representative cells
(high or low BrdU staining) are shown. Top two rows show cells exhibiting the granular pattern. (B) SMCX DNA was transfected into cells, and 2
days after transfection cells were synchronized with aphidicolin. One day later, cells were released from the aphidicolin block, and SMCX levels
were monitored at indicated intervals using western blotting. (C) This experiment was designed as in (B), except that transfection was not
performed and endogenous SMCX levels were monitored. Cyclin A = cyclin A levels, a cell-cycle synchronization control; cyclin A levels increase
in late G1 and stay high through the S phase. H3 = histone H3, a loading control for the chromatin fraction. Other terminology as in Figure 5.

Liang et al. Epigenetics & Chromatin 2011, 4:18
http://www.epigeneticsandchromatin.com/content/4/1/18

In

antifade reagent (number P36930; ProLong® Gold; Invitrogen Corp.) and cured overnight before pictures were
taken (Eclipse TE-2000S; Nikon, Tokyo, Japan).
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Synchronization experiments

293T cells were plated onto 60 mm dishes and tranfected
with the SMCX plasmid as described above. Two days
after transfection, aphidicolin was added to a final concentration of 5 mg/ml. One day later, the aphidicolin-containing medium was removed and cells washed. Standard
medium was added, then cells were harvested at the indicated intervals and analyzed by western blotting. The
experiment described in Figure 3C was performed in a
similar manner, except that cells were not transfected with
the SMCX plasmid.

Results
Figure 4 Association of SMCX (Smcy homolog, X-linked
(mouse)) and proliferating cell nuclear antigen (PCNA). 293T
cells were transfected with the SMCX-encoding plasmid, and
chromatin lysates prepared 2 days after transfection. Lysates were
then immunoprecipitated with anti-SMCX, anti-PCNA, or control
normal rabbit or mouse IgG, respectively. Some lysates were
pretreated with DNAse, as described in Methods. SMCX and PCNA
were detected by western blotting. D = DNAse-pretreated samples,
immunnoprecipitated with the corresponding antibody, Ig = control
normal IgG (mouse for the anti-PCNA antibody (top), and rabbit for
the anti-SMCX antibody (bottom)), In = input lysate, P = samples
immunoprecipitated with the anti-PCNA antibody, S = samples
immunoprecpitated with the anti-SMCX antibody.

was removed by centrifugation. The samples were then
loaded onto SDS-PAGE and processed as described above
for western blotting. The DNAse pre-treatment was performed as described previously [19].
Immunofluorescence

293T cells were plated onto four-well slides (Lab Tek
Chamber;Thermo Scientific, Rochestyer NY)] at a density
of 4 × 105 per well. The next day cells were exposed to
BrdU for 3 hours at a concentration of 10 μmol/L. Cells
were washed once with PBS and then fixed with cold
methanol for 20 minutes. DNA was then denatured by
two consecutive treatments with 4 mol/L HCL for 15 minutes each. Cells were then washed with PBS and incubated
with antibodies diluted 1:50 in PBS with 3% BSA (antiBrdU conjugated to Alexa Fluor 594 and anti-SMCX, or a
control with no antibody) overnight at 4°C. The next day,
cells were washed with PBS containing Tween 20, and
then incubated with a secondary donkey anti-rabbit antibody targeting SMCX (controls consisted of a well with no
antibody, or a well with secondary antibody alone; data not
shown) in PBS with 3% BSA for 1 hour at room temperature. Cells were then washed with PBS with 3% BSA, then
incubated with DAPI for 5 minutes, then mounted with

Association of overexpressed SMCX in chromatin depends
on proliferating cell nuclear antigen

Because endogenous SMCX expression is reported to be
low in most types of somatic cells, except neurons [8], we
initially used an overexpression approach and transiently
overexpressed SMCX under control of the CMV promoter. Overexpressed SMCX was found to be present in both
whole-cell lysates and the chromatin fraction (Figure 1),
but the levels in chromatin, although still significant, were
lower than those in the whole-cell lysates.
We then treated cells with siRNA targeting PCNA.
PCNA knockdown strikingly reduced the amount of
SMCX in chromatin (Figure 1). Control siRNA did not
affect SMCX levels in the chromatin fraction, and PCNA
siRNA did not significantly affect the overall SMCX
levels in the whole-cell lysate (results were quantified by
densitometry, data not shown). H3K4me3 levels inversely
correlated with SMCX levels in chromatin. Our results
thus show that PCNA is required for the entry of exogenous SMCX into chromatin.
Association of endogenous SMCX with chromatin also
depends on PCNA

293T cells do express SMCX, although at very low levels.
Large amounts of protein lysate are required to detect
endogenous SMCX by western blotting. Thus, to investigate whether our conclusions can be extended to endogenous SMCX, we transfected 293T cells with PCNA
siRNA, and examined the levels of endogenous SMCX in
chromatin. DNA knockdown also reduced levels of endogenous SMCX (Figure 2). This result also supports our
initial conclusion that PCNA is required for SMCX association with chromatin.
SMCX associates with proliferating cell nuclear antigen

PCNA carries binding sites for a large number of transcription factors and other chromatin-associated
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Figure 5 Association with proliferating cell nuclear antigen (PCNA) and Intracellular distribution of SMCX (Smcy homolog, X-linked
(mouse)) PCNA-interaction protein motif (PIP box) mutants. (A) Intracellular distribution of PIP mutants. 293T cells were transfected with
plasmid encoding SMCX and mutated SMCX Two days after transfection, cells were harvested, then the chromatin fraction was separated from
the rest of the lysate and both fractions analyzed by western blotting. SMCX mutants in chromatin: SMCX = normal SMCX, F1209A = F to A
mutant (see text), L1204A = L to A mutant, Q1201A = Q to A mutant. H3 and GAPDH served as loading controls. Ch = chromatin fraction, W-Ch
= cell lysate without chromatin (bottom), (B) Association of PIP mutants with PCNA 293T cells were transfected as in (A). Two days after
transfection, cells were harvested, whole-cell lysates prepared and immunoprecipitated with PCNA. SMCX and PIP mutants in
immunoprecipitates were detected using western blotting. Terminology as in (A).
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proteins [20]. We hypothesized that SMCX may associate with PCNA, similar to other proteins that affect
chromatin structure. To test this hypothesis, we performed co-immunoprecipitation experiments and analyzed SMCX levels in PCNA immunoprecipitates of the
chromatin fraction and vice versa. SMCX co-immunoprecipitates with PCNA (Figure 4), and thus we conclude that SMCX associates with PCNA.
We also tested the hypothesis that the PCNA-SMCX
interaction is mediated by DNA. Thus, samples were pretreated by DNAse, as described previously [19]. The treatment did not affect the levels of co-immunoprecipitated
SMCX or PCNA., indicating that SMCX-PCNA co-immunoprecipitation reflects protein-protein interaction.
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SMCX PIP box mutants exhibit reduced association with
chromatin

To test the hypothesis that the putative SMCX PIP box
mediates the interaction with PCNA and loading SMCX
onto chromatin, we mutated three of the conserved residues within the PIP box (F, L and Q; Figure 6), and investigated whether these mutant proteins associate with
PCNA and chromatin. We found that mutations of F to A,
L to A and Q to A all led to reduced co-immunoprecipitation of SMCX and PCNA (Figure 5B), Similarly, all three
mutants were reduced in chromatin compared with normal SMCX (Figure 5A). We conclude that the amino
acids of the SMCX PIP box control the interaction of
SMCX with PCNA and the loading of SMCX onto
chromatin.

SMCX contains a PIP box

The PIP box,[NQ]xx(L/I/M/V)xx (F/Y/W), is found in
some PCNA-interacting proteins, such as the p21 (WAF1/
CIP1) protein [20,21], and it interacts with the interdomain connector loop (IDCL) of PCNA. Because PCNA is
a homotrimer, it is possible that complexes containing up
to three PCNA-interacting proteins can be assembled on a
single PCNA ring. For example, each of the subunits in a
human PCNA trimer can simultaneously bind to a different flap endonuclease (FEN)-1 molecule [22,23].
Another novel PCNA-binding motif, K-A-(A/L/I)-(A/
L/Q)-x-x-(L/V), is termed the KA box. It is distinct
from the ‘classic’ PIP box and is also present in several
PCNA-interacting proteins [20]. To determine if SMCX
contains either of these PCNA-interacting motifs, we
performed an analysis of the SMCX protein sequence
using the ScanProsite program. We identified a PIP box
in the SMCX protein (Figure 6A): - - Q- - L- - -WF- -.
The full amino acid sequence is: - -QCDLCQDWF- -.

SMCX association with proliferating cell nuclear antigen is
regulated by the cell cycle

PIP box in proteins of the regulatory element-1-silencing
transcription factor complex

Discussion
SMCX/JARID1C is a recently discovered H3K4 demethylase, which belongs to a family of JARID1 proteins that
also contains the demethylases SMCY (JARID1D), RBP2
(JARID1A) and PLU1 (JARID1C). These two latter
demethylases share SMCX preferences for H3K4me3 and
H3K4me2 [8]. However, the SMCX gene was identified
before the discovery of its demethylase activity and its
mutations were associated with X-linked mental retardation (XMLR), which affects 1 in 500 males. This gene is
also one of the few that escape from inactivation of the
mammalian X chromosome [9]. A novel mutation was
found recently in the SMCX gene of a patient with ASD,
and it may be responsible for producing the autism phenotype in this patient [15]. It was thus thought that the
SMCX role is restricted to neurons and, it was consistently
shown that SMCX expression during zebrafish development is highest in the brain, and that SMCX is required
for neuron survival and dendritic development [8].

We then tested a hypothesis that SMCX association with
PCNA is indirect, and is mediated by another protein,
rather than the SMCX PIP box. Because SMCX is a component of a protein complex that contains REST, the histone deacetylases HDAC1 and HDAC2, and the histone
methyltransferase G9a, we analyzed these proteins for the
presence of a PIP box motif, and found one in the G9a
protein (Figure 6B). The motif is of the type found in
SMCX. This finding prompted tanother question: does
PCNA bring SMCX into chromatin directly, or is SMCX
brought into chromatin by interacting with G9a, which in
turn interacts directly with PCNA?
To address this issue, we knocked down G9a in 293T
cells using siRNA. We found that G9a knockdown did not
affect chromatin levels of SMCX (see Additional file 1, Figure S1), supporting the hypothesis that the entry of SMCX
into chromatin is due to direct interaction with PCNA.

PCNA is mainly expressed in S phase. To determine if
SMCX levels similarly fluctuate inside cells during the cell
cycle, we performed immunofluorescence experiments,
and found that SMCX was expressed both in cells with
strong staining with anti-BrdU antibody (S phase) and in
cells showing very little BrdU staining (Figure 3A). However, SMCX in S phase cells had a different, granular pattern of distribution compared with other cells. This result
suggests a possible SMCX redistribution in S phase.
Cells were then synchronized with aphidicolin at the
G1/S interface, and released by removing the drug. Both
exogenous and endogenous SMCX had very high upregulation in the chromatin fraction after entry into S phase
(Figure 3B, C). We thus conclude that SMCX is present in
chromatin mainly in S phase, which correlates with the
expression pattern of PCNA.
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Figure 6 Profliferating cell nuclear antigen-interaction protein motif (PIP box) boxes in SMCX (Smcy homolog, X-linked (mouse)) and
G9a. PIP boxes were identified as described in Methods. (A) SMCX; (B) G9a; (C) comparison of SMCX, G9a and WRN (Werner
syndrome protein) PIP boxes. SMCX domains: BRIGHT = DNA binding domain, JmjC = JmjC domain, JmjN = JmjN domain, PHD1 = PHDfinger 1, PHD2 = PHD-finger 2, Zn = zinc finger. G9a domains: ANK = Ankyrin repeats domain, Pre-set = Pre-set motif, Post-set = Post-set
domain, Set = Set domain.

Nevertheless, other results argue for an additional role
of SMCX in non-neuronal cells. SMCX was found to be
ubiquitously expressed during early mammalian development [8], and it is also involved in E2-mediated repression of papillomavirus oncogenes. In addition, SMCX
levels were found to be increased in prostate and seminoma cancers and to be absent in renal carcinomas

[24,25]. Finally, SMCX was found in a protein complex
with REST, which represses transcription of neuronal
genes in non-neuronal tissues, and was recently found to
play a tumor suppressor role in breast cancer by suppression of the oncogenic TAC1 (tachykinin, precursor 1)
protein [7,26]. These results support a role for SMCX in
non-neuronal, dividing cells.
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SMCX is one of the few known H3K4 demethylases, and
H3K4 methylation is a crucial epigenetic modification that
regulates both transcription and the DNA-damage
response [27,28]. In addition, SMCX has been shown to
play a role in disease development (see above). It is thus
crucial to understand the cellular regulation of SMCX
function. Unfortunately, very little is known about how
this gene and protein are regulated. Some information can
be inferred from yeast, which contains the SMCX homolog, Jhd2 [29]. Levels of Jhd2 protein in yeast are modulated through polyubiquitylation by the E3 ubiquitin ligase
Not4 and its turnover is mediated by the proteasome [30].
Polyubiquitin-mediated degradation of Jhd2 controls in
vivo H3K4 trimethylation and gene-expression levels.
Human NOT4 can also polyubiquitylate JARID1C/SMCX,
a human homolog of Jhd2, suggesting that this is probably
a conserved mechanism [30].
In this study, we showed that SMCX entry into chromatin depends on PCNA, which is found in complex
with SMCX. SMCX contains a PIP box, whose amino
acids are important for the association of SMCX with
PCNA and chromatin. PCNA is expressed by dividing
cells, predominantly in the S phase of the cell cycle, when
it associates with replication forks [31]. Our results support a role for SMCX in dividing cells, in addition to neurons, possibly in the establishment and maintenance of
H3K4 methylation patterns during and after the S phase
of the cell cycle.

Conclusions
In summary, our data indicate that the intracellular trafficking of SMCX is controlled by its association with
PCNA.
Additional material
Additional file 1: Figure S1. Effects of G9a knockdown on chromatin
levels of SMCX (Smcy homolog, X-linked (mouse)). 293T cells were
transfected with the SMCX-encoding plasmid and anti-G9a, antiproliferating cell nuclear antigen, or control small interfering RNA. Two
days after transfection, cells were harvested. The chromatin fraction was
separated from the rest of the lysate, and analyzed by western blotting.

List of abbreviations
DMEM: Dulbecco’s modified Eagle’s medium; DAPI: 4’,6-diamidino-2phenylindole; FBS: fetal bovine serum; GADPH: glyceraldehyde 3-phosphate
dehydrogenase; PBS: phosphate-buffered saline; SDS-PAGE: sodium dodecyl
sulphate polyacrylamide gel electrophoresis
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